CORT
HealthcareCorcept Therapeutics Incorporated
$32.12-0.27 (-0.83%)
Prev Close
$32.39
Open
$32.77
High
$33.12
Low
$31.81
Volume
591.6K
Market Cap
$3.60B
P/E
36.92
Div Yield
—
Over the past 12 months, insider activity at Corcept Therapeutics Incorporated (CORT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 71 insider sales totaling $129.48M. The most recent insider transaction was by Guyer William (officer: Chief Development Officer), who sold $296.3K worth of shares on Mar 6, 2026. Corcept Therapeutics Incorporated operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $3.60B.
Buys (12M)
0
$0.00
Sells (12M)
71
$129.48M
Net Activity
Net Seller
$129.48M
Active Insiders
10
last 12 mo
CORT Price Chart
CORT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026↗ | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231 |
| Feb 9, 2026↗ | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026↗ | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235 |
| Feb 3, 2026↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026↗ | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235 |
| Jan 6, 2026↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
| Dec 24, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 80,284 | $83.59 | $6.71M | 0 |
| Dec 1, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $79.77 | $3.19M | 0 |
| Dec 1, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $80.08 | $1.60M | 0 |
| Dec 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,110 | $79.53 | $406.4K | 0 |
| Dec 1, 2025↗ | Maduck Sean | See Remarks | Sell | 20,135 | $79.53 | $1.60M | 0 |
| Dec 1, 2025↗ | Mokari Atabak | Chief Financial Officer | Sell | 118 | $79.78 | $9.4K | 0 |
| Dec 1, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 148 | $79.78 | $11.8K | 0 |
| Nov 25, 2025↗ | Guyer William | Chief Development Officer | Sell | 4,500 | $80.90 | $364.1K | 0 |
| Nov 5, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $75.36 | $1.51M | 0 |
| Nov 3, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $74.58 | $2.98M | 0 |
| Nov 3, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $73.65 | $368.2K | 0 |
| Nov 3, 2025↗ | Maduck Sean | See Remarks | Sell | 20,000 | $73.99 | $1.48M | 0 |
| Oct 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $87.54 | $192.6K | 0 |
| Oct 7, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $89.94 | $1.80M | 0 |
| Oct 1, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $85.08 | $3.40M | 0 |
| Oct 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $84.75 | $423.8K | 0 |
| Oct 1, 2025↗ | Maduck Sean | See Remarks | Sell | 20,000 | $85.06 | $1.70M | 0 |
| Sep 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $72.45 | $159.4K | 0 |
| Sep 4, 2025↗ | Cannon Gillian | Director | Sell | 3,607 | $70.13 | $253.0K | 0 |
| Sep 2, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $70.53 | $2.82M | 0 |
| Sep 2, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $70.49 | $1.41M | 0 |
| Sep 2, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,189 | $70.29 | $364.7K | 0 |
| Sep 2, 2025↗ | Maduck Sean | See Remarks | Sell | 20,233 | $70.50 | $1.43M | 0 |
| Sep 2, 2025↗ | Mokari Atabak | Chief Financial Officer | Sell | 144 | $71.38 | $10.3K | 0 |
| Sep 2, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 256 | $71.38 | $18.3K | 0 |
| Aug 22, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 5,000 | $71.22 | $356.1K | 0 |
| Aug 11, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $72.30 | $159.1K | 0 |
| Aug 8, 2025↗ | Guyer William | Chief Development Officer | Sell | 35,007 | $71.77 | $2.51M | 0 |
| Aug 5, 2025↗ | Guyer William | Chief Development Officer | Sell | 14 | $71.77 | $1.0K | 0 |
| Aug 1, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $68.53 | $2.74M | 0 |
| Aug 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,823 | $67.51 | $393.1K | 0 |
| Jul 17, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 615 | $73.69 | $45.3K | 0 |
| Jul 17, 2025↗ | Guyer William | Chief Development Officer | Sell | 4,879 | $73.48 | $358.5K | 0 |
| Jul 17, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 4,077 | $73.47 | $299.5K | 0 |
| Jul 17, 2025↗ | Maduck Sean | See Remarks | Sell | 4,788 | $73.47 | $351.8K | 0 |
| Jul 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $71.08 | $156.4K | 0 |
| Jul 1, 2025↗ | Guyer William | Chief Development Officer | Sell | 100 | $73.51 | $7.4K | 0 |
| Jul 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 100 | $73.51 | $7.4K | 0 |
| Jul 1, 2025↗ | Maduck Sean | See Remarks | Sell | 205 | $73.45 | $15.1K | 0 |
| Jun 16, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 3,185 | $70.77 | $225.4K | 0 |
| Jun 12, 2025↗ | Maduck Sean | See Remarks | Sell | 35,007 | $67.79 | $2.37M | 0 |
| Jun 10, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $72.42 | $1.45M | 0 |
| Jun 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $70.61 | $155.3K | 0 |
Showing 1–50 of 183
1 / 4
CORT Insider Buying Activity
The following table shows recent insider purchases of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
No insider buying activity found for CORT in the last 12 months.
CORT Insider Selling Activity
The following table shows recent insider sales of Corcept Therapeutics Incorporated (CORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026↗ | Guyer William | officer: Chief Development Officer | Sell | 8,233 | $35.99 | $296.3K | 2,231 |
| Feb 9, 2026↗ | Hunt Hazel | Chief Scientific Officer | Sell | 77,968 | $41.31 | $3.22M | 0 |
| Feb 5, 2026↗ | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 1,235 |
| Feb 3, 2026↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $40.87 | $817.3K | 0 |
| Jan 8, 2026↗ | Guyer William | officer: Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 1,235 |
| Jan 6, 2026↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $35.18 | $703.7K | 0 |
| Dec 24, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 306,846 | $83.59 | $25.65M | 0 |
| Dec 24, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 80,284 | $83.59 | $6.71M | 0 |
| Dec 1, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $79.77 | $3.19M | 0 |
| Dec 1, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $80.08 | $1.60M | 0 |
| Dec 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,110 | $79.53 | $406.4K | 0 |
| Dec 1, 2025↗ | Maduck Sean | See Remarks | Sell | 20,135 | $79.53 | $1.60M | 0 |
| Dec 1, 2025↗ | Mokari Atabak | Chief Financial Officer | Sell | 118 | $79.78 | $9.4K | 0 |
| Dec 1, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 148 | $79.78 | $11.8K | 0 |
| Nov 25, 2025↗ | Guyer William | Chief Development Officer | Sell | 4,500 | $80.90 | $364.1K | 0 |
| Nov 5, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $75.36 | $1.51M | 0 |
| Nov 3, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $74.58 | $2.98M | 0 |
| Nov 3, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $73.65 | $368.2K | 0 |
| Nov 3, 2025↗ | Maduck Sean | See Remarks | Sell | 20,000 | $73.99 | $1.48M | 0 |
| Oct 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $87.54 | $192.6K | 0 |
| Oct 7, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $89.94 | $1.80M | 0 |
| Oct 1, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $85.08 | $3.40M | 0 |
| Oct 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,000 | $84.75 | $423.8K | 0 |
| Oct 1, 2025↗ | Maduck Sean | See Remarks | Sell | 20,000 | $85.06 | $1.70M | 0 |
| Sep 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $72.45 | $159.4K | 0 |
| Sep 4, 2025↗ | Cannon Gillian | Director | Sell | 3,607 | $70.13 | $253.0K | 0 |
| Sep 2, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $70.53 | $2.82M | 0 |
| Sep 2, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $70.49 | $1.41M | 0 |
| Sep 2, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,189 | $70.29 | $364.7K | 0 |
| Sep 2, 2025↗ | Maduck Sean | See Remarks | Sell | 20,233 | $70.50 | $1.43M | 0 |
| Sep 2, 2025↗ | Mokari Atabak | Chief Financial Officer | Sell | 144 | $71.38 | $10.3K | 0 |
| Sep 2, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 256 | $71.38 | $18.3K | 0 |
| Aug 22, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 5,000 | $71.22 | $356.1K | 0 |
| Aug 11, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $72.30 | $159.1K | 0 |
| Aug 8, 2025↗ | Guyer William | Chief Development Officer | Sell | 35,007 | $71.77 | $2.51M | 0 |
| Aug 5, 2025↗ | Guyer William | Chief Development Officer | Sell | 14 | $71.77 | $1.0K | 0 |
| Aug 1, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 40,000 | $68.53 | $2.74M | 0 |
| Aug 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 5,823 | $67.51 | $393.1K | 0 |
| Jul 17, 2025↗ | BELANOFF JOSEPH K | Chief Executive Officer | Sell | 615 | $73.69 | $45.3K | 0 |
| Jul 17, 2025↗ | Guyer William | Chief Development Officer | Sell | 4,879 | $73.48 | $358.5K | 0 |
| Jul 17, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 4,077 | $73.47 | $299.5K | 0 |
| Jul 17, 2025↗ | Maduck Sean | See Remarks | Sell | 4,788 | $73.47 | $351.8K | 0 |
| Jul 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $71.08 | $156.4K | 0 |
| Jul 1, 2025↗ | Guyer William | Chief Development Officer | Sell | 100 | $73.51 | $7.4K | 0 |
| Jul 1, 2025↗ | Lyon Joseph Douglas | See Remarks | Sell | 100 | $73.51 | $7.4K | 0 |
| Jul 1, 2025↗ | Maduck Sean | See Remarks | Sell | 205 | $73.45 | $15.1K | 0 |
| Jun 16, 2025↗ | Robb Gary Charles | Chief Business Officer | Sell | 3,185 | $70.77 | $225.4K | 0 |
| Jun 12, 2025↗ | Maduck Sean | See Remarks | Sell | 35,007 | $67.79 | $2.37M | 0 |
| Jun 10, 2025↗ | Guyer William | Chief Development Officer | Sell | 20,000 | $72.42 | $1.45M | 0 |
| Jun 10, 2025↗ | Swisher Daniel N JR | Director | Sell | 2,200 | $70.61 | $155.3K | 0 |
CORT Insiders
Similar Stocks to CORT
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B